Cosmo Pharmaceuticals N.V. (CMOPF)
OTCMKTS
· Delayed Price · Currency is USD
55.00
-7.80 (-12.42%)
At close: Apr 10, 2025
Cosmo Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 9, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 902 | 1,128 | 972 | 1,084 | 1,212 | 1,390 | Upgrade
|
| Market Cap Growth | 16.07% | 16.07% | -10.39% | -10.51% | -12.80% | 19.98% | Upgrade
|
| Enterprise Value | 750 | 995 | 926 | 1,041 | 1,170 | 1,305 | Upgrade
|
| Last Close Price | 55.00 | 66.93 | 52.65 | 68.90 | 72.45 | 89.20 | Upgrade
|
| PE Ratio | 6.54 | 8.18 | - | 58.91 | 49.16 | - | Upgrade
|
| PS Ratio | 3.27 | 4.08 | 9.48 | 9.94 | 16.37 | 18.64 | Upgrade
|
| PB Ratio | 1.73 | 2.16 | 2.18 | 2.19 | 2.08 | 2.84 | Upgrade
|
| P/TBV Ratio | 2.79 | 3.48 | 3.43 | 14.09 | 9.52 | 2.87 | Upgrade
|
| P/FCF Ratio | 5.52 | 6.90 | 45.41 | 35.34 | 149.55 | 128.14 | Upgrade
|
| P/OCF Ratio | 5.37 | 6.71 | 38.72 | 30.54 | 84.48 | 87.48 | Upgrade
|
| EV/Sales Ratio | 2.47 | 3.60 | 9.03 | 9.54 | 15.80 | 17.50 | Upgrade
|
| EV/EBITDA Ratio | 4.09 | 5.99 | 90.38 | 23.65 | 57.74 | 176.12 | Upgrade
|
| EV/EBIT Ratio | 4.43 | 6.46 | - | 34.71 | 92.64 | 590.89 | Upgrade
|
| EV/FCF Ratio | 4.59 | 6.09 | 43.26 | 33.92 | 144.35 | 120.31 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.37 | 0.33 | 0.42 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.18 | 4.14 | 9.20 | 24.49 | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.01 | 0.10 | 6.05 | 23.85 | 18.97 | Upgrade
|
| Asset Turnover | 0.46 | 0.46 | 0.14 | 0.13 | 0.09 | 0.10 | Upgrade
|
| Inventory Turnover | 3.27 | 3.27 | 3.06 | 3.29 | 3.50 | 4.66 | Upgrade
|
| Quick Ratio | 3.39 | 3.39 | 3.22 | 1.45 | 11.77 | 11.06 | Upgrade
|
| Current Ratio | 4.19 | 4.19 | 4.07 | 1.57 | 12.99 | 11.60 | Upgrade
|
| Return on Equity (ROE) | 29.31% | 29.31% | -2.47% | 3.58% | 4.75% | -1.99% | Upgrade
|
| Return on Assets (ROA) | 15.87% | 15.87% | -0.18% | 2.24% | 0.99% | 0.19% | Upgrade
|
| Return on Capital (ROIC) | 20.39% | 20.39% | -0.22% | 2.66% | 1.11% | 0.20% | Upgrade
|
| Return on Capital Employed (ROCE) | 24.90% | 24.90% | - | 5.00% | 1.40% | 0.30% | Upgrade
|
| Earnings Yield | 15.29% | 12.23% | -1.23% | 1.70% | 2.03% | -0.70% | Upgrade
|
| FCF Yield | 18.11% | 14.49% | 2.20% | 2.83% | 0.67% | 0.78% | Upgrade
|
| Dividend Yield | - | 3.17% | 4.20% | 1.63% | 1.49% | - | Upgrade
|
| Payout Ratio | 24.09% | 24.09% | - | 90.61% | - | - | Upgrade
|
| Buyback Yield / Dilution | -1.94% | -1.94% | 1.95% | 2.83% | -16.81% | 1.11% | Upgrade
|
| Total Shareholder Return | -1.94% | 1.23% | 6.15% | 4.46% | -15.32% | 1.11% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.